About
Glyconics Ltd is a UK-based medical diagnostics company founded in 2013 and headquartered in Colchester, Essex. The company specializes in developing affordable, needle-free, point-of-care diagnostic devices that provide rapid results within minutes. Utilizing miniaturized Infrared (IR) Spectroscopy technology, Glyconics identifies specific disease biomarkers in biological samples, enhancing disease screening and monitoring. The company designs and manufactures proprietary handheld devices equipped with advanced algorithms that analyze molecular "fingerprints" produced by IR light. This innovative approach allows for the quick and accurate differentiation between healthy and non-healthy samples. Glyconics primarily targets major chronic diseases, including Chronic Obstructive Pulmonary Disease (COPD) and Diabetes, aiming to improve early detection and ongoing monitoring for better health outcomes. Their products are intended for use by healthcare workers and patients, promoting self-care and patient involvement in managing chronic conditions.
Technologies
Keywords
Company Information
-
Employees 5
-
Founded 2013
-
Annual Revenue $40830000
-
Total Funding $2239868
Location
Phoenix Way, Norwich, England, United Kingdom, NR5 0